Showing 1981-1990 of 2889 results for "".
- Reveal Lasers Launches Eternahttps://modernaesthetics.com/news/reveal-lasers-launches-eterna-topic/2473419/Reveal Lasers LLC is launching Eterna, a radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables. "We are thrilled to introduce Eterna to the market," says Bob Daley, CEO of Reveal Lasers, in a
- Cartessa Aesthetics Introduces Helix by DEKAhttps://modernaesthetics.com/news/cartessa-aesthetics-introduces-helix-by-deka/2473418/Cartessa Aesthetics is rolling out Helix by DEKA, a fractional ablative CO2 and non-ablative technologies in one device. The US is the first market to make HELIX commercially available. HELIX features pulse shape control for CoolPeel treatment and adds a 1570nm fiber lase
- Sentient Introduces Tixel in the UShttps://modernaesthetics.com/news/sentient-introduces-tixel-in-the-us/2473416/Sentient is rolling out Sentient Tixel in the US. Sentient Tixel uses thermal-mechanical action technology to resurface skin. Tixel technology uniquely combines heat with the forward motion of a medical-grade titanium tip without the use of lasers, radiation, ultrasound, or needles.
- FDA Approves Skinvive by Juvéderm to Improve Skin Smoothness in Cheekshttps://modernaesthetics.com/news/fda-approves-skinvive-by-juvederm-to-improve-skin-smoothness-in-cheeks/2473415/The U.S. Food and Drug Administration gave its nod to Skinvive by Juvéderm to improve skin smoothness of the cheeks in adults over the age of 21. Skinvive by Juvéderm is the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin smoothness availabl
- Dr. Shiv Sabesan Named CTO at Cytrellishttps://modernaesthetics.com/news/dr-shiv-sabesan-named-cto-at-cytrellis/2473409/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- TAKE 5 WITH PETER KANG, CEO, COOLHEALTHhttps://modernaesthetics.com/news/take-5-with-peter-kang-ceo-coolhealth/2473406/Peter Kang, CEO of CoolHealth, chatted with Modern Aesthetics® magazine about the company and their first launch. TargetCool, a cooling device that takes cooling to the next level, provides temporary analgesia to the skin before aesthetic injections including fillers, neuromodulators, and pla
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Nadav Tomer is Cynosure’s New CEOhttps://modernaesthetics.com/news/nadav-tomer-is-cynosures-new-ceo/2473399/Nadav Tomer is Cynosure’s new chief executive officer, effective May 1, 2023. He succeeds Todd Tillemans, who will step down and will work closely with Mr. Tomer to ensure a smooth transition. "Nadav has an incredibly strong track record of operation
- Study: “Stuck” Stem Cells Turn Hair Grayhttps://modernaesthetics.com/news/study-stuck-stem-cells-turn-hair-gray/2473396/Certain stem cells move between growth compartments in hair follicles, but they can get stuck as people age and lose their ability to mature and maintain hair color, a new study shows. The new work focused on cells in the skin of mice and also found in humans called melanocyt
- Plastic Surgeons Among Top Earners in 2022https://modernaesthetics.com/news/plastic-surgeons-among-top-earners-in-2023/2473393/The highest paid specialties in 2022 included plastic surgery ($619,000), orthopedics ($573,000), cardiology ($507,000) and urology ($506,000), according to the 2023 Medscape Physician Compensation Report. Dermatologists made about $443,000 in 2022. T